Catherine A. Lichten

Catherine Lichten
Cambridge Office


Ph.D. in computational biology, McGill University; B.Sc. in mathematics, McGill University

Media Resources

This researcher is available for interviews.

To arrange an interview, contact RAND Europe Media Relations at +44 (1223) 353 329, x2560, or email

More Experts


Catherine Lichten is an analyst at RAND Europe working primarily in areas related to science and health. Her RAND research projects have examined a range of topics in the area of biomedical research funding and the interface of science and society.

Before joining RAND Europe, Lichten worked as a journalist covering research policy and funding news for London-based publications Research Fortnight and Research Europe, where she wrote about topics such as researcher mobility and diversity, research infrastructure, and responsible innovation.

Lichten holds a Ph.D. in computational biology and a B.Sc. in mathematics from McGill University in Canada.

Recent Projects

  • Evaluating the EU's Action Plan Against Antimicrobial Resistance (AMR)
  • Mapping the UK's Dementia Research Landscape and Workforce Capacity
  • Validating the Outcomes of the 'Science 2.0: Science in Transition' Public Consultation
  • The Future of Anticoagulation for Management of Atrial Fibrillation
  • Venture Research: Fostering Trust and Freedom in Research Funding


  • MRSA bacteria or superbug bacteria

    Europe's Fight Against Antimicrobial Resistance

    The EC's AMR Action Plan included measures to ensure antimicrobials are used more appropriately in both humans and animals and measures to stimulate R&D of new antibiotics. One area that was not sufficiently covered was the environment.

    Nov 3, 2016 E!Sharp

  • Hereford cattle eating at a trough

    The Global Economic Costs of Antimicrobial Resistance

    In addition to being a public health problem, antimicrobial resistance is also a major economic concern. It crosses sectoral boundaries, because resistant bugs can pass between animals and humans, and through food, agriculture, and the environment.

    May 20, 2016 Cultures Magazine

  • Stethoscope on an ECG

    What Does the Future Hold for Atrial Fibrillation?

    Longer-term thinking, enhanced public awareness, and more thorough engagement among stakeholders are critical components of a strategy to deal with atrial fibrillation.

    Jun 2, 2015